Natco Pharma, Eris Lifesciences shares jump up to 6% on partnership for Semaglutide launch in IndiaShares of Natco Pharma and Eris Lifesciences climbed on Tuesday after announcing a partnership to commercialise Semaglutide in India. Natco...
24 Feb, 2026, 04.31 PM IST
Eris Lifesciences shares in focus on move to acquire Swiss Parenterals in Rs 423 crore dealEris Lifesciences is set to fully acquire its injectable unit, Swiss Parenterals. The deal involves a share swap valued at Rs 423.3 crore. ...
25 Nov, 2025, 08.31 AM IST
Buy Eris Lifesciences, target price Rs 1100: Prabhudas LilladherEris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.
23 May, 2024, 09.24 AM IST
Neutral on Eris Lifesciences, target price Rs 930: Motilal OswalEris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.
15 Mar, 2024, 10.37 AM IST
Buy Eris Lifesciences, target price Rs 1070: HDFC SecuritiesEris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.
13 Mar, 2024, 10.54 AM IST
Buy Eris Lifesciences, target price Rs 1050: Prabhudas LilladherEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 12633.84 Crore) operating in Pharmac...
08 Jan, 2024, 10.57 AM IST
Buy Eris Lifesciences, target price Rs 710: Motilal Oswal Financial ServicesEris Lifesciences, incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 7871.82 Crore) operating in Pharmaceutica...
17 Mar, 2023, 10.35 AM IST
Buy Eris Lifesciences, target price Rs 780: Motilal Oswal Financial ServicesEris Lifesciences, incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 8701.37 Crore) operating in Pharmaceutica...
18 Jan, 2023, 01.03 PM IST
Buy Eris Lifesciences, target price Rs 825: Prabhudas LilladherEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 9395.71 Crore) operating in Pharmace...
01 Sep, 2022, 11.44 AM IST
Buy Eris Lifesciences, target price Rs 850: Prabhudas LilladherEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 8921.10 Crore) operating in Pharmace...
08 Jul, 2022, 09.49 AM IST
Eris Lifesciences Q3 Results: Profit rises to Rs 101 croreRevenue stood at Rs 332 crore in the third quarter of the current fiscal as compared to Rs 310 crore in the year-ago period, Eris Lifescien...
28 Jan, 2022, 05.58 PM IST
Buy Eris Lifesciences, target price Rs 880: ICICI DirectEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 10371.61 Crore) operating in Pharmac...
02 Jul, 2021, 11.07 AM IST
Buy Eris Lifesciences, target price Rs 660: Yes SecuritiesEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 8217.45 Crore) operating in Pharmace...
26 Mar, 2021, 08.58 AM IST
Eris Lifesciences Q3 results: Net profit up 42% at Rs 90 croreConsolidated total revenue from operations of the company stood at Rs 310.42 crore for the quarter under consideration. It was Rs 266.39 cr...
28 Jan, 2021, 03.08 PM IST
Buy Eris Lifesciences, target price Rs 690: Haitong SecuritiesThe brokerage values Eris at a 20 per cent premium to its mid-cap peers.
21 Apr, 2020, 08.24 AM IST
Eris Lifesciences, Shasun Strides shares rise on Rs 500 crore dealThe India branded generics business being divested by Strides had sales of Rs 181 core FY 2017, the statement said.
20 Nov, 2017, 04.08 PM IST
Eris Lifesciences makes modest BSE debut, rises 1.5% over issue priceThe IPO, which was sold in Rs 600-603 band during June 16-20, was subscribed 3.29 times.
29 Jun, 2017, 04.31 PM IST